Pages
All Departments
Let's get Social
Copyright Here. All rights reserved.
BYWWW.WSJ.COMJuly 14, 2017
Johnson & Johnson has agreed to acquire Actelion Ltd. for $30 billion, in an unusual deal that will also spin out the Swiss biotech company’s drug-discovery operations.